| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1K | — | — |
| R&D Expense | $943K | -2.7% | -16.9% |
| SG&A Expense | $731K | +9.5% | -26.4% |
| Operating Income | -$1.7M | -3.6% | +19.1% |
| Net Income | -$1.5M | -2.4% | +11.7% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.1M | -9.3% | -59.4% |
| Short-term Investments | $19.8M | -0.1% | +227.3% |
| Current Assets | $33.8M | -1.6% | -12.0% |
| Total Assets | $33.9M | -1.6% | -12.0% |
| Total Liabilities | $725K | -2.2% | +78.4% |
| Stockholders' Equity | $32.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.9M | — | — |
| Investing Cash Flow | -$17.0M | — | — |
| Financing Cash Flow | -$668K | — | — |
| -12.1% |